These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Sone S, Nakayama T, Honda T, Tsushima K, Li F, Haniuda M, Takahashi Y, Suzuki T, Yamanda T, Kondo R, Hanaoka T, Takayama F, Kubo K, Fushimi H. Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180 [Abstract] [Full Text] [Related]
5. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA. Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317 [Abstract] [Full Text] [Related]
6. Present strategy of lung cancer screening and surgical management. Ikeda N, Hayashi A, Miura Y, Okunaka T, Okuzawa K, Tsuboi M, Kato Y, Suga Y, Kato H. Ann Thorac Cardiovasc Surg; 2005 Dec; 11(6):363-6. PubMed ID: 16401983 [Abstract] [Full Text] [Related]
7. Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial. Maisonneuve P, Bagnardi V, Bellomi M, Spaggiari L, Pelosi G, Rampinelli C, Bertolotti R, Rotmensz N, Field JK, Decensi A, Veronesi G. Cancer Prev Res (Phila); 2011 Nov; 4(11):1778-89. PubMed ID: 21813406 [Abstract] [Full Text] [Related]
11. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [Abstract] [Full Text] [Related]
15. The variation of prognostic significance of Maximum Standardized Uptake Value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma. Casali C, Cucca M, Rossi G, Barbieri F, Iacuzio L, Bagni B, Uliano M. Lung Cancer; 2010 Aug; 69(2):187-93. PubMed ID: 19942313 [Abstract] [Full Text] [Related]
16. Lung cancer prognostic factors from the Aichi Cancer Registry. Kato I, Tominaga S, Ikari A. Jpn J Clin Oncol; 1990 Sep; 20(3):238-45. PubMed ID: 2174996 [Abstract] [Full Text] [Related]
17. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (</=20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours). Makimoto Y, Nabeshima K, Iwasaki H, Miyoshi T, Enatsu S, Shiraishi T, Iwasaki A, Shirakusa T, Kikuchi M. Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599 [Abstract] [Full Text] [Related]
18. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases]. Yi SZ, Zhang DC, Wang YG, Sun KL. Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770 [Abstract] [Full Text] [Related]